Foghorn Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Foghorn Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Foghorn Therapeutics Inc
Rating: 1.40525
Author: Trendlyne DVM scores

about

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, ...

5.25 -0.20 (-3.67%)

48.73% Fall from 52W High

163.3K

XNAS Volume

XNAS 31 Jul, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Foghorn Therapeutics Inc is on 08 Aug 2025 for the purpose of Foghorn Therapeutics Inc Second Quarter Earnings Results for 2025 See details